Saturday 17 October 2026
Export EDSA’s income statement to Excel — free account
Edesa Biotech, Inc.
EDSA Healthcare Biotechnology
In the quarter to June 2026, EPS fell 140.0% and free cash flow fell 81.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
2.57
0.10
−3.75%
Follow EDSA
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 3 | 4 | 4 | 3 | — |
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 211.30 | 53.95 | 18.56 | 51.09 | 16.65 |
Altman Z-Score |
— | — | — | — | — | 22.29 | 38.67 | (1.51) | 12.18 | 15.91 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | — | 1.81 | 10.73 | 12.83 | 5.96 | 13.83 |
P/Operating CF |
— | — | — | — | — | (41.53) | (10.06) | (1.02) | (10.44) | (17.76) |
Beneish M-Score |
— | — | — | — | — | (4.36) | (0.10) | — | — | (2.07) |
P/B ratio |
— | — | — | — | — | 10.48 | 5.97 | 0.35 | 1.58 | 1.72 |
Price to Tangible BV |
— | — | — | — | — | 16.75 | 5.97 | 0.35 | 1.58 | 1.72 |
EV/Sales |
— | — | — | — | — | 189.37 | 45.30 | (29.41) | 22.33 | 7.68 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 1.29 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | (12.49) | (3.37) | 1.37 | (1.08) | (2.17) |
EV/FCF |
— | — | — | — | — | (12.61) | (3.22) | 1.26 | (1.02) | (1.99) |
Quick Ratio |
10.60 | 0.71 | 3.29 | 3.90 | 7.64 | 4.77 | 11.37 | 20.97 | 20.46 | 18.43 |
Current Ratio |
10.67 | 0.91 | 3.53 | 4.25 | 8.29 | 5.30 | 12.23 | 21.60 | 21.06 | 19.40 |
Net Debt/EBITDA |
1.39 | 0.15 | 0.59 | 0.39 | 0.33 | 1.14 | 1.78 | 2.11 | 1.30 | 2.40 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.05 | 0.02 | 0.02 | 0.11 |
Operating CF/Net income |
1.02 | 0.79 | 0.79 | 0.70 | 1.02 | 0.78 | 1.75 | 0.92 | 0.93 | 0.90 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.05) | (0.05) | 0.33 | 0.00 | (2.03) | (1.69) | (2.69) |
| (277.81%) | (136.66%) | (101.88%) | (156.34%) | (135.54%) | (107.08%) | (33.57%) | (53.93%) | (51.04%) | (49.47%) | |
| (82.86%) | (97.13%) | (81.84%) | (134.16%) | (105.28%) | (77.23%) | (31.74%) | (51.68%) | (48.70%) | (43.10%) | |
ROIC |
(297.91%) | (464.48%) | (341.61%) | (499.12%) | (283.59%) | (211.18%) | (784.95%) | (322.88%) | (391.67%) | (337.67%) |
Return on Tangible Assets |
(68.86%) | 3,924.94% | (181.12%) | (252.00%) | (125.32%) | (96.59%) | (52.83%) | (44.89%) | (68.75%) | (41.09%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 97.02 | 192.85 | 71.00 | 2.08 | 24.63 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,012.62% | 266.83% | 985.55% | 864.39% | 135.99% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,028.77% | 497.76% | 1,301.89% | 1,289.97% | 261.29% |
Intangible Assets out of Total Assets |
0.15 | 0.55 | 0.25 | 0.20 | 0.16 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 182.00% | 0.00% | 72.85% | 50.59% | 20.40% |
Graham Net Nets |
— | — | — | — | — | 0.09 | 0.17 | 2.55 | 0.55 | 0.54 |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (9.17%) | (10.36%) | (124.69%) | (100.99%) | (23.31%) |
Free Cash Flow Yield |
— | — | — | — | — | (7.11%) | (26.11%) | (125.35%) | (42.89%) | (23.19%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.57 | 3.10 | 6.56 | 42.39 |
Operating CF per Share |
(1.29) | (1.53) | (2.32) | (5.86) | (7.92) | (4.05) | (6.73) | (67.58) | (135.05) | (150.19) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | (5.60) | (8.70) | (13.41) |
Free Cash Flow per Share |
(1.29) | (1.53) | (2.32) | (5.86) | (7.92) | (4.04) | (6.73) | (73.18) | (143.74) | (163.60) |
Cash per Share |
1.90 | 0.32 | 1.88 | 3.38 | 4.54 | 5.87 | 6.99 | 150.86 | 188.66 | 380.19 |
Shareholders Equity per Share |
2.19 | 0.62 | 2.47 | 4.48 | 7.57 | 7.41 | 7.30 | 165.25 | 212.62 | 410.47 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.19 | 0.62 | 2.47 | 4.48 | 7.57 | 7.41 | 7.30 | 165.25 | 212.62 | 410.47 |
Free Cash Flow |
(7.32) | (4.89) | (6.64) | (12.28) | (13.67) | (4.97) | (4.85) | (5.00) | (5.00) | (4.91) |
Working Capital |
10.43 | (0.16) | 4.62 | 6.95 | 10.63 | 6.57 | 5.18 | 10.16 | 6.44 | 11.48 |
Capital Expenditures |
— | — | — | (0.01) | (0.01) | 0.02 | (0.01) | (0.38) | (0.30) | (0.40) |
Net Current Asset Value |
10.43 | (0.16) | 4.60 | 6.91 | 10.56 | 6.45 | 5.18 | 10.16 | 6.44 | 11.48 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 1.24 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.00 | (0.06) | 0.00 | 1.81 | 1.33 | 0.32 |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 0.00 | 21.09 | 9.31 | 7.92 | 3.89 | 0.07 | 0.18 | 0.20 | 0.20 |
Cash ROIC |
(31.50%) | (162.01%) | (53.48%) | (74.53%) | (65.42%) | (30.43%) | (47.11%) | (23.15%) | (35.82%) | (20.69%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.16 | 3.18 | 9.97 | 5.24 | 10.45 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.21 | 1.09 | 1.13 | 1.76 |
Inventory Turnover |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.67 | 3.05 | 3.37 | 2.80 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30,280.48 | 1,663.22 | 404.43 | 219.14 | 201.82 |
Days of Inventory on Hand |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 183.85 | 46.50 | 80.72 |
Average Receivables |
0.46 | 0.45 | 0.94 | 2.28 | 1.70 | 0.15 | 0.13 | 0.02 | 0.04 | 0.12 |
Average Payables |
1.45 | 1.78 | 1.93 | 1.75 | 1.42 | 0.96 | 0.48 | 0.41 | 0.47 | 0.64 |
Average Inventory |
— | — | — | — | — | — | 0.15 | 0.15 | 0.16 | 0.40 |
Average Assets |
8.67 | 6.35 | 10.23 | 13.08 | 12.67 | 8.24 | 8.75 | 9.75 | 10.33 | 11.66 |
Average Common Equity |
2.59 | 4.52 | 8.22 | 11.22 | 9.84 | 5.94 | 8.27 | 9.34 | 9.86 | 10.16 |
Columns are period end dates